Modified release formulations and uses thereof
AssigneeSunovion Pharmaceuticals Inc.
InventorsTakumi Asada, Gerald R. Galluppi, Seth Cabot Hopkins, Megumi Maruyama, Siriporn Toongsuwan, Yuki Tsushima
Life of this patent
Estimating the term…
Loading patent…
AssigneeSunovion Pharmaceuticals Inc.
InventorsTakumi Asada, Gerald R. Galluppi, Seth Cabot Hopkins, Megumi Maruyama, Siriporn Toongsuwan, Yuki Tsushima
Estimating the term…
Provided are modified release compositions in a solid oral dosage form comprising amisulpride in the form of an unequal mixture of (R)-amisulpride and (S)-amisulpride, or pharmaceutically acceptable salts thereof, where the amount of (R)-amisulpride is greater than the amount of (S)-amisulpride, and medicaments comprising the same used for the treatment of various diseases and disorders, and methods of using same for the treatment of various diseases and disorders, including, but not limited to, dosage regimens. In addition, provided are formulations employing polymorphs of enantiomeric amisulpride.
1-116. (canceled)
A solid dosage form composition comprising from about 100 to about 600 mg of a non-racemic mixture of amisulpride by weight of the free base, comprising:
Dependencies are inferred from the claim text.